Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Non-motor Parkinson's: integral to motor Parkinson's, yet often neglected.

Todorova A, Jenner P, Ray Chaudhuri K.

Pract Neurol. 2014 Oct;14(5):310-22. doi: 10.1136/practneurol-2013-000741. Review.

2.

[Effect of gastroenterological disorders on the quality of life in patients with Parkinson's disease].

Iablonskaia AIu, Fedorova NV, Loranskaia ID.

Eksp Klin Gastroenterol. 2009;(4):72-6. Russian.

PMID:
19960997
3.

Parkinson's disease: the non-motor issues.

Chaudhuri KR, Odin P, Antonini A, Martinez-Martin P.

Parkinsonism Relat Disord. 2011 Dec;17(10):717-23. doi: 10.1016/j.parkreldis.2011.02.018. Review.

PMID:
21741874
4.

The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease.

Martinez-Martin P, Rodriguez-Blazquez C, Kurtis MM, Chaudhuri KR; NMSS Validation Group..

Mov Disord. 2011 Feb 15;26(3):399-406. doi: 10.1002/mds.23462.

PMID:
21264941
5.

Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease.

Santos-García D, de la Fuente-Fernández R.

J Neurol Sci. 2013 Sep 15;332(1-2):136-40. doi: 10.1016/j.jns.2013.07.005.

PMID:
23890935
6.

Clinical problems in non-fluctuating patients with Parkinson's disease: a community-based study.

Larsen JP, Karlsen K, Tandberg E.

Mov Disord. 2000 Sep;15(5):826-9.

PMID:
11009186
7.

AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study.

Stocchi F, Rascol O, Destee A, Hattori N, Hauser RA, Lang AE, Poewe W, Stacy M, Tolosa E, Gao H, Nagel J, Merschhemke M, Graf A, Kenney C, Trenkwalder C.

Mov Disord. 2013 Nov;28(13):1838-46. doi: 10.1002/mds.25561.

PMID:
23853029
8.

Importance of motor vs. non-motor symptoms for health-related quality of life in early Parkinson's disease.

Müller B, Assmus J, Herlofson K, Larsen JP, Tysnes OB.

Parkinsonism Relat Disord. 2013 Nov;19(11):1027-32. doi: 10.1016/j.parkreldis.2013.07.010.

PMID:
23916654
9.
10.

Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.

Barone P, Poewe W, Albrecht S, Debieuvre C, Massey D, Rascol O, Tolosa E, Weintraub D.

Lancet Neurol. 2010 Jun;9(6):573-80. doi: 10.1016/S1474-4422(10)70106-X.

PMID:
20452823
11.

[Assessment of hyper- and hypodopaminergic behaviors in Parkinson's disease].

Ardouin C, Chéreau I, Llorca PM, Lhommée E, Durif F, Pollak P, Krack P; groupe évaluation comportementale de la maladie de Parkinson..

Rev Neurol (Paris). 2009 Nov;165(11):845-56. doi: 10.1016/j.neurol.2009.06.003. Review. French.

PMID:
19683776
12.

Association between fatigue and other motor and non-motor symptoms in Parkinson's disease patients.

Solla P, Cannas A, Mulas CS, Perra S, Corona A, Bassareo PP, Marrosu F.

J Neurol. 2014 Feb;261(2):382-91. doi: 10.1007/s00415-013-7207-5.

PMID:
24375016
13.

Levodopa-related wearing-off in Parkinson's disease: identification and management.

Pahwa R, Lyons KE.

Curr Med Res Opin. 2009 Apr;25(4):841-9. doi: 10.1185/03007990902779319 . Review.

PMID:
19228103
14.

Economic and health-related quality of life considerations of new therapies in Parkinson's disease.

Rubenstein LM, DeLeo A, Chrischilles EA.

Pharmacoeconomics. 2001;19(7):729-52. Review.

PMID:
11548910
15.

The burden of non-motor symptoms in Parkinson's disease using a self-completed non-motor questionnaire: a simple grading system.

Chaudhuri KR, Sauerbier A, Rojo JM, Sethi K, Schapira AH, Brown RG, Antonini A, Stocchi F, Odin P, Bhattacharya K, Tsuboi Y, Abe K, Rizos A, Rodriguez-Blazquez C, Martinez-Martin P.

Parkinsonism Relat Disord. 2015 Mar;21(3):287-91. doi: 10.1016/j.parkreldis.2014.12.031.

PMID:
25616694
16.

Relationships between disability, quality of life and prevalence of nonmotor symptoms in Parkinson's disease.

Leonardi M, Raggi A, Pagani M, Carella F, Soliveri P, Albanese A, Romito L.

Parkinsonism Relat Disord. 2012 Jan;18(1):35-9. doi: 10.1016/j.parkreldis.2011.08.011.

PMID:
21880537
17.
18.

A randomized trial of deep-brain stimulation for Parkinson's disease.

Deuschl G, Schade-Brittinger C, Krack P, Volkmann J, Schäfer H, Bötzel K, Daniels C, Deutschländer A, Dillmann U, Eisner W, Gruber D, Hamel W, Herzog J, Hilker R, Klebe S, Kloss M, Koy J, Krause M, Kupsch A, Lorenz D, Lorenzl S, Mehdorn HM, Moringlane JR, Oertel W, Pinsker MO, Reichmann H, Reuss A, Schneider GH, Schnitzler A, Steude U, Sturm V, Timmermann L, Tronnier V, Trottenberg T, Wojtecki L, Wolf E, Poewe W, Voges J; German Parkinson Study Group, Neurostimulation Section..

N Engl J Med. 2006 Aug 31;355(9):896-908. Erratum in: N Engl J Med. 2006 Sep 21;355(12):1289.

19.

Early Parkinson's disease and non-motor issues.

Chaudhuri KR, Naidu Y.

J Neurol. 2008 Sep;255 Suppl 5:33-8. doi: 10.1007/s00415-008-5006-1. Review.

PMID:
18787880
20.

Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.

Honig H, Antonini A, Martinez-Martin P, Forgacs I, Faye GC, Fox T, Fox K, Mancini F, Canesi M, Odin P, Chaudhuri KR.

Mov Disord. 2009 Jul 30;24(10):1468-74. doi: 10.1002/mds.22596.

PMID:
19425079
Items per page

Supplemental Content

Support Center